Inspire Medical Systems, Inc.
INSP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $802,804 | $624,799 | $407,856 | $233,394 |
| % Growth | 28.5% | 53.2% | 74.7% | – |
| Cost of Goods Sold | $122,986 | $96,576 | $66,115 | $33,279 |
| Gross Profit | $679,818 | $528,223 | $341,741 | $200,115 |
| % Margin | 84.7% | 84.5% | 83.8% | 85.7% |
| R&D Expenses | $114,128 | $116,536 | $68,645 | $37,350 |
| G&A Expenses | $434,707 | $351,658 | $0 | $0 |
| SG&A Expenses | $529,607 | $451,958 | $320,688 | $202,615 |
| Sales & Mktg Exp. | $94,900 | $100,300 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $643,735 | $568,494 | $389,333 | $239,965 |
| Operating Income | $36,083 | -$40,271 | -$47,592 | -$39,850 |
| % Margin | 4.5% | -6.4% | -11.7% | -17.1% |
| Other Income/Exp. Net | $22,370 | $20,365 | $3,324 | -$2,120 |
| Pre-Tax Income | $58,453 | -$19,906 | -$44,268 | -$41,970 |
| Tax Expense | $4,944 | $1,247 | $613 | $72 |
| Net Income | $53,509 | -$21,153 | -$44,881 | -$42,042 |
| % Margin | 6.7% | -3.4% | -11% | -18% |
| EPS | 1.8 | -0.72 | -1.6 | -1.54 |
| % Growth | 350% | 55% | -3.9% | – |
| EPS Diluted | 1.75 | -0.72 | -1.6 | -1.54 |
| Weighted Avg Shares Out | 29,763 | 29,302 | 28,072 | 27,263 |
| Weighted Avg Shares Out Dil | 30,543 | 29,302 | 28,072 | 27,263 |
| Supplemental Information | – | – | – | – |
| Interest Income | $23,247 | $20,560 | $5,050 | $125 |
| Interest Expense | $22 | $0 | $1,677 | $2,128 |
| Depreciation & Amortization | $6,550 | $2,846 | $1,858 | $1,218 |
| EBITDA | $65,025 | -$17,060 | -$40,733 | -$38,624 |
| % Margin | 8.1% | -2.7% | -10% | -16.5% |